An experimental new treatment could prolong the lives of patients with the most aggressive form of brain cancer.
Researchers from several institutions collaborated to develop a viral therapy that attack brain cancer cells from the inside.
Preliminary results show the treatment increased the survival of 43 Glioblastoma patients from seven months to 13-and-a-half months.
And 40-percent of patients who received the highest doses were still alive after two years.
During the first step of treatment, a patient is given an injection of Toca 511, a modified virus that infects cancer cells.
Then the patients is prescribed oral cycles of Toca FC, an antifungal drug.
